Relación entre el cáncer de ovario y la inducción de la ovulación. Mito o realidad.

[1] Atlas M. and Menczer J. Massive hyperstimulation and borderline carcinoma of the ovary. A possible association. Acta Obstet Gynecol Scand 1982, 61:261-263.[Medline]
[2] Bamford P.N. and Steele S.J. Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report. Br J Obstet Gynaecol 1982, 89:962-964.[Medline]
[3] Ben-Hur H., Dgani R., Lancet M., Katz Z., Nissim F. and Rosenman D. Ovarian carcinoma masquerading as ovarian hyperstimulation syndrome. Acta Obstet Gynecol Scand. 1986, 65:813-814.[Medline]
[4] Dietl J. Ovulation and ovarian cancer. Lancet 1991, 338:445.[Medline]
[5] Kulkarni R. and McGarry J.M. Follicular stimulation and ovarian cancer. BMJ 1989, 299:740.[Medline]
[6] Ron E., Lunenfeld B., Menczer J., Blumstein Z., Katz L. and Oelsner G. et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987, 125:780-790.[Medline]
[7] Blankstein J., Shalev J., Saadon T., Kukia E.E., Rabinovici J. and Pariente C. et al. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertil Steril 1987, 47:597-602.[Medline]
[8] Hack M., Brish M., Serr D.M., Insler V. and Lunenfeld B. Outcome of pregnancy after induced ovulation. Follow-up of pregnancies and children born after gonadotropin therapy. JAMA 1970, 211:791-797.[Medline]
[9] Whittemore A.S., Harris R. and Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992, 136:1184-1203.[Medline]
[10] Harris R., Whittemore A.S. and Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992, 136:1204-1211.[Medline]
[11] Rossing M.A., Daling J.R., Weiss N.S., Moore D.E. and Self S.G. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994, 331:771-776.[Medline]
[12] Shushan A., Paltiel O., Ischovich J., Elchalal U., Peretz T. and Schenker J.G. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996, 65:13-18.[Medline]
[13] Carter M.E. and Joyce D.N. Ovarian carcinoma in a patient hyperstimulated by gonadotropin therapy for in vitro fertilization: a case report. J In Vitro Fert Embryo transf 1987, 4:126-128.[Medline]
[14] Fishel S. and Jackson P. Follicular stimulation for high tech pregnancies(s): are we playing it safe? BMJ 1989, 299:309-311.[Medline]
[15] Nijman H.W., Burger C.W., Baak J.P.A., Schats R., Vermorken J.B. and Kenemans P. Borderlin